20472 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
Breast and prostate cancer treatment method
#302Liquid depot formulations
#3037-keto DHEA for psychiatric use
#304Formulations
#305Pharmaceutical Compositions
#306Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus
#307Use of aromatase inhibitors for treatment of ectopic pregnancy
#308Pharmaceutical compositions
#309Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
#310Opioid depot formulations
#311Transdermal Steriod for Formulation
#312Administration of non-oral androgenic steroids to women
#313Use of sex steroid function modulators to treat wounds and fibrotic disorders
#314Enhancement of urogenital function
#315Substances and agents for positively influencing collagen
#316Probiotic enterococci for improved immunity
#317Surrogate markers
#318Drug product and process for making
#319Blockade of mtor to prevent a hormonal adaptive response
#320Novel methods for the preparation of dhea derivatives
#321Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S)
#322Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer
#323Method for treating erectile dysfunction and increasing libido in men
#324Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
#325Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression
#326Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
#327Combination of organic compounds
#328Co-administration of dehydroepiandrosterone (DHEA) congener with parthenolide for treating inflammation
#329Treatment screening methods
#330Treatment screening methods
#331Tetrol steroids and esters
#332Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
#333Pharmaceutical compositions and treatment methods-7
#334Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#335Asthma and colitis treatment methods
#336Combination therapy for the treatment of estrogen-sensitive drugs
#337Combination therapy for the treatment of estrogen-sensitive disease
#338Modified aromatase inhibitors having improved bioavailability
#339Combination therapy for the treatment of estrogen-sensitive disease
#340Pharmaceutical compositions and treatment methods - 8
#341Pharmaceutical composition and method for treating hypogonadism
#342Combination therapy for the treatment of estrogen-sensitive disease
#343Composition and method for treatment of neurophysiological conditions and maintenance of neurophysiological health
#344Method of treating breast cancer
#345Pharmaceutical composition and method for treating hypogonadism
#346Treatment of subnormal bone mineral density
#347Pharmaceutical composition and method for treating hypogonadism
#348Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#349Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#350Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#351Neurological disorder treatment methods
#352Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and aromatase inhibitors
#353Combination of organic compounds
#354Method for treating erectile dysfunction and increasing libido in men
#355Method for treating erectile dysfunction and increasing libido in men
#356Lipid profile modulation
#357Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
#358Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
#359Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
#360Production of insulin by testosterone olfaction